SlideShare a Scribd company logo
1 of 29
Incidental Adnexal Masses Detected at Low-
Dose Unenhanced CT in Asymptomatic
Women Age 50 and Older:
Implications for Clinical Management and
Ovarian Cancer Screening
©RSNA, 2010 • radiology.rsna.org
By
Dr. Naglaa Mahmoud
Registrar of Clinical Radiology
KCCC
Introduction:
Ovarian cancer remains the leading cause of gynecologic
cancer–related deaths in the United States.
Five-year survival for ovarian cancer is greater than 90% for
localized disease, but the overall survival is well below 50%
because the majority of cases are advanced at diagnosis.
Introduction:
Unlike transvaginal ultrasonography or MR imaging, CT is
not intended for primary pelvic or gynecologic evaluation in
women. However, the widespread use of abdominal / pelvic
CT for a variety of other indications unavoidably includes
adnexal evaluation, often resulting in incidental lesion
detection.
Introduction:
In the case of CT colonography screening in asymptomatic
postmenopausal women, the identification of adnexal
lesions nearly always represents an unsuspected
incidental finding which allows for a unique opportunity to
investigate this well-suited cohort.
The purpose of this study was:
To determine the prevalence, work-up, and outcomes of
indeterminate adnexal masses identified at low-dose
unenhanced CT scan in asymptomatic women age 50 and
older undergoing colonography screening.
Materials and Methods:
This study was institutional review board approved.
Informed consent was waived.
The fate of indeterminate adnexal lesions identified at
unenhanced CT in 2869 consecutive women (mean age,
57.2 years; age range, 50–97 years) undergoing
colonography screening between April 2004 and
December 2008 was evaluated.
CT Technique
CT imaging of the abdomen and pelvis was performed for
the purpose of colorectal cancer screening by using a
colonographic technique.
The preimaging protocol for colonography includes bowel
preparation the evening before examination and gaseous
distention of the colon during the examination.
CT Technique
Supine and prone acquisitions were obtained with 8 or 16-
detector CT scanners by utilizing 1.25-mm collimation, 120
kVp, static (50–75 mAs) tube current technique, and 1-mm
reconstruction interval.
For extracolonic evaluation, the supine series was
reconstructed with a 5-mm section thickness at 3-mm
intervals.
CT Technique
Extracolonic CT interpretation was performed alongside the
prospective colorectal evaluation by one of five board-certified
abdominal radiologists, all with at least 10 years of experience
in gastrointestinal and genitourinary body CT interpretation.
Prospective categorization of extracolonic findings was applied
in all cases by utilizing the CT Colonography Reporting and
Data System (C-RADS).
CT Technique
According to C-RADS, E1 (normal finding) and E2
(unimportant finding) categories do not require further
work-up, whereas E3 (likely benign but incompletely
characterized) and E4 (potentially or definitely important)
findings often necessitate further evaluation.
Identification of the Study Cohort
The positive study cohort was defined by the presence
of an adnexal lesion with a C-RADS category of E3 or
E4.
Results:
One hundred eighteen women (mean age, 56.2 years),
representing 4.1% of the screening cohort, had an
indeterminate adnexal mass (108 unilateral, 10 bilateral; Mean
size, 4.1 cm) at prospective CT interpretation.
A total of 80 women underwent some combination of further
imaging evaluation (n = 76) (transvaginal ultrasonography [ n =
71], pelvic magnetic resonance imaging [ n = 7], contrast
material– enhanced CT [ n = 7]) and/or surgery ( n = 26).
Results:
Mean serum CA-125 level in 33 women was 12.8 U/mL;
levels were normal ( < 35 U/mL) in 32 (97%) cases (range,
3–26 U/mL) and mildly elevated (41 U/mL) in 1 case.
Results:
Final pathologic findings of surgically excised lesions were
cystadenoma or cystadenofibroma ( n = 14; 11 serous, three
mucinous); non neoplastic cysts ( n = 5; two
endometriomas); mature teratoma ( n = 3); hydrosalpinx ( n =
2); fibroma (n = 1); and benign Brenner tumor ( n = 1).
Three additional teratomas were diagnosed at index CT only.
No ovarian cancers were prospectively identified.
Various adnexal pathologic findings identified at routine CT colonography
screening and surgically removed after further work-up. CT colonographic
images in six women (age range, 51–63 years) show
(a)mucinous cystadenoma,
(b)bilateral serous cystadenomas,
(c) ovarian fibroma,
(d) endometrioma,
(e) paraovarian inclusion cyst, and (f) hydrosalpinx
Results:
A systematic search for subsequent diagnosis of ovarian
cancer in the larger cohort of 2751 women without an
adnexal mass of C-RADS category E3 or E4 at CT
colonography revealed 4 cases of ovarian cancer that
manifested 15–44 months (mean, 26.8 months) after a
negative finding at CT examination.
Results:
Pathologic diagnoses included 2 cases of mucinous
cystadenocarcinoma, 1 case of papillary serous carcinoma,
and 1 case of a poorly differentiated adenocarcinoma for
which ovarian versus peritoneal origin could not be
ascertained.
Mucinous cystadenocarcinoma that manifested 3 years after negative findings at CT
colonography screening examination in 67-year-old woman.
(a) Index CT colonographic image demonstrates symmetric-appearing normal
ovaries.
(b) Diagnostic contrast-enhanced CT image obtained 3 years later shows a large
complex solid and cystic mass, which originated from the left ovary.
Discussion:
Ovarian cancer has a greater annual mortality than cervical and
endometrial cancers combined.
Prognosis remains poor in most cases because the disease is
usually advanced at diagnosis.
Discussion
Although effective screening for ovarian cancer is highly
desirable, there is currently no convincing evidence that it can
reduce mortality among average-risk women. The findings of
this study further support this unfortunate situation.
Furthermore, a negative finding at CT was not protective
against subsequent development of ovarian cancer, with all
four cases occurring in this cohort.
Discussion:
The main factors that diminish the potential utility of
screening are that indolent benign adnexal lesions are
relatively common in postmenopausal women, but ovarian
cancer is relatively rare and tends to grow rapidly.
Management algorithms generally recommend further work-
up of nearly all discrete adnexal masses detected at CT in
postmenopausal women.
Discussion:
In contrast to ovarian cancer, a number of other
extracolonic cancers have been identified at CT
colonography screening, generally at an early
presymptomatic stage with a favorable outcome.
This suggests that ovarian cancer is an aggressive tumor
that has a rather narrow window for presymptomatic
screening that may preclude effective screening detection in
the general population.
Discussion:
More sophisticated risk factor assessment may be required
to effectively identify and manage high-risk cases to improve
the overall yield of ovarian cancer screening.
Established risk factors include BRCA mutations, Lynch
syndrome, family history of ovarian or breast cancer, and a
personal history of breast cancer.
Limitations of the study
All CT examinations were performed by using a colonographic
technique with low-dose imaging and without intravenous
contrast material.
With the exception of ovarian teratomas, the ability to fully
characterize adnexal masses at low-dose unenhanced CT is
limited.
Conclusion:
Incidental indeterminate adnexal lesions were relatively
common at unenhanced CT scan (4.1%), but subsequent
work-up revealed no ovarian cancers.
Furthermore, a normal finding at CT was not protective
against short-term development of ovarian cancer.
More sophisticated risk factor assessment is needed to
identify women at higher risk.
Thank you

More Related Content

What's hot

Staging and Diagnostic approach of rectal cancer
 Staging and Diagnostic approach  of rectal cancer Staging and Diagnostic approach  of rectal cancer
Staging and Diagnostic approach of rectal cancerDr.Bhavin Vadodariya
 
Ovarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahOvarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahAyub Medical College
 
Ovarian carcinoma by Dr najeeb ur rehman
Ovarian carcinoma by Dr najeeb ur rehmanOvarian carcinoma by Dr najeeb ur rehman
Ovarian carcinoma by Dr najeeb ur rehmanAyub Medical College
 
05052008OvarianTelehealth
05052008OvarianTelehealth05052008OvarianTelehealth
05052008OvarianTelehealthFlavio Guzmán
 
Report from ISSUOG CONGRESS, SYDNEY, 2013
Report from ISSUOG CONGRESS, SYDNEY, 2013Report from ISSUOG CONGRESS, SYDNEY, 2013
Report from ISSUOG CONGRESS, SYDNEY, 2013hungnguyenthien
 
The differential diagnosis of benign and malignant adnexial masses
The differential diagnosis of benign and malignant adnexial massesThe differential diagnosis of benign and malignant adnexial masses
The differential diagnosis of benign and malignant adnexial massesTevfik Yoldemir
 
Dubai endom cancer march 2013 final
Dubai endom cancer march 2013 finalDubai endom cancer march 2013 final
Dubai endom cancer march 2013 finalTariq Mohammed
 
Screening in ovarian cancers
Screening in ovarian cancersScreening in ovarian cancers
Screening in ovarian cancersAshutosh Mukherji
 
DWI borderline / malignant epithelial ovarian tumors
DWI borderline / malignant epithelial ovarian tumorsDWI borderline / malignant epithelial ovarian tumors
DWI borderline / malignant epithelial ovarian tumorsNaglaa Mahmoud
 
Gynaecological cancers staging and treatment
Gynaecological cancers   staging and treatmentGynaecological cancers   staging and treatment
Gynaecological cancers staging and treatmentsailakshmidaayana
 
Ovarian cancer 1
Ovarian cancer 1Ovarian cancer 1
Ovarian cancer 1ZahidAli224
 
CES202101 - Clase 15 parte 1 - Cáncer de cérvix
CES202101 - Clase 15 parte 1 - Cáncer de cérvix CES202101 - Clase 15 parte 1 - Cáncer de cérvix
CES202101 - Clase 15 parte 1 - Cáncer de cérvix Mauricio Lema
 
Urology gynecology ri renal tumor p taourel
Urology gynecology ri renal tumor p taourelUrology gynecology ri renal tumor p taourel
Urology gynecology ri renal tumor p taourelJFIM
 

What's hot (20)

Staging and Diagnostic approach of rectal cancer
 Staging and Diagnostic approach  of rectal cancer Staging and Diagnostic approach  of rectal cancer
Staging and Diagnostic approach of rectal cancer
 
Ovarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullahOvarian carcinoma by Dr wasif ullah
Ovarian carcinoma by Dr wasif ullah
 
Ovarian carcinoma by Dr najeeb ur rehman
Ovarian carcinoma by Dr najeeb ur rehmanOvarian carcinoma by Dr najeeb ur rehman
Ovarian carcinoma by Dr najeeb ur rehman
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
05052008OvarianTelehealth
05052008OvarianTelehealth05052008OvarianTelehealth
05052008OvarianTelehealth
 
Report from ISSUOG CONGRESS, SYDNEY, 2013
Report from ISSUOG CONGRESS, SYDNEY, 2013Report from ISSUOG CONGRESS, SYDNEY, 2013
Report from ISSUOG CONGRESS, SYDNEY, 2013
 
The differential diagnosis of benign and malignant adnexial masses
The differential diagnosis of benign and malignant adnexial massesThe differential diagnosis of benign and malignant adnexial masses
The differential diagnosis of benign and malignant adnexial masses
 
Dubai endom cancer march 2013 final
Dubai endom cancer march 2013 finalDubai endom cancer march 2013 final
Dubai endom cancer march 2013 final
 
Screening in ovarian cancers
Screening in ovarian cancersScreening in ovarian cancers
Screening in ovarian cancers
 
figo ovary staging update
figo ovary staging updatefigo ovary staging update
figo ovary staging update
 
DWI borderline / malignant epithelial ovarian tumors
DWI borderline / malignant epithelial ovarian tumorsDWI borderline / malignant epithelial ovarian tumors
DWI borderline / malignant epithelial ovarian tumors
 
Ovary 1
Ovary 1Ovary 1
Ovary 1
 
Uterine Cancer
Uterine CancerUterine Cancer
Uterine Cancer
 
Gynaecological cancers staging and treatment
Gynaecological cancers   staging and treatmentGynaecological cancers   staging and treatment
Gynaecological cancers staging and treatment
 
Mello Abrams Lecture: Ovarian Cancer Update: Beth Karlan, MD
Mello Abrams Lecture: Ovarian Cancer Update: Beth Karlan, MD Mello Abrams Lecture: Ovarian Cancer Update: Beth Karlan, MD
Mello Abrams Lecture: Ovarian Cancer Update: Beth Karlan, MD
 
Ovarian cancer
Ovarian cancerOvarian cancer
Ovarian cancer
 
ovarian tumor
ovarian tumorovarian tumor
ovarian tumor
 
Ovarian cancer 1
Ovarian cancer 1Ovarian cancer 1
Ovarian cancer 1
 
CES202101 - Clase 15 parte 1 - Cáncer de cérvix
CES202101 - Clase 15 parte 1 - Cáncer de cérvix CES202101 - Clase 15 parte 1 - Cáncer de cérvix
CES202101 - Clase 15 parte 1 - Cáncer de cérvix
 
Urology gynecology ri renal tumor p taourel
Urology gynecology ri renal tumor p taourelUrology gynecology ri renal tumor p taourel
Urology gynecology ri renal tumor p taourel
 

Similar to Incidental Adnexal Masses at CT

Screening for ovarian cancer may 15
Screening for ovarian cancer  may 15Screening for ovarian cancer  may 15
Screening for ovarian cancer may 15Basalama Ali
 
Screening for ovarian cancer may 15
Screening for ovarian cancer  may 15Screening for ovarian cancer  may 15
Screening for ovarian cancer may 15Basalama Ali
 
Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docxOriginal StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docxvannagoforth
 
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.comServikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Surgical treatment of potentially primary malignant adrenal tumors | Γιώργος...
Surgical treatment of potentially primary malignant adrenal tumors | Γιώργος...Surgical treatment of potentially primary malignant adrenal tumors | Γιώργος...
Surgical treatment of potentially primary malignant adrenal tumors | Γιώργος...Γιώργος Ζωγράφος
 
Surgical mgmt of axilla in Breast ca patients with negative SLN biopsy.pptx
Surgical mgmt of axilla in Breast ca patients with negative SLN biopsy.pptxSurgical mgmt of axilla in Breast ca patients with negative SLN biopsy.pptx
Surgical mgmt of axilla in Breast ca patients with negative SLN biopsy.pptxHemanta Pun
 
TUMOR MARKERS OF COLORECTAL CARCINOMA
TUMOR MARKERS OF  COLORECTAL CARCINOMATUMOR MARKERS OF  COLORECTAL CARCINOMA
TUMOR MARKERS OF COLORECTAL CARCINOMAMoustafa Rezk
 
S E L E C T I V E A X I L L A R Y D I S S E C T I O N I N
S E L E C T I V E  A X I L L A R Y  D I S S E C T I O N  I NS E L E C T I V E  A X I L L A R Y  D I S S E C T I O N  I N
S E L E C T I V E A X I L L A R Y D I S S E C T I O N I NAnil Haripriya
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comjinekolojivegebelik.com
 
Co-relation of multidetector CT scan based preoperative staging with intra-op...
Co-relation of multidetector CT scan based preoperative staging with intra-op...Co-relation of multidetector CT scan based preoperative staging with intra-op...
Co-relation of multidetector CT scan based preoperative staging with intra-op...Apollo Hospitals
 
Scans and Ovarian Cancer: Everything You Want to Know
Scans and Ovarian Cancer: Everything You Want to KnowScans and Ovarian Cancer: Everything You Want to Know
Scans and Ovarian Cancer: Everything You Want to Knowbkling
 
Imaging in breast cancer
Imaging in breast cancerImaging in breast cancer
Imaging in breast cancerDeepika Malik
 
Ovarian Tumors, Diagnosis Or Prognosis
Ovarian Tumors, Diagnosis Or PrognosisOvarian Tumors, Diagnosis Or Prognosis
Ovarian Tumors, Diagnosis Or PrognosisGalal Lotfi
 
MCO 2011 - Slide 34 - N. Pavlidis - Spotlight session - Cancer of unknown pri...
MCO 2011 - Slide 34 - N. Pavlidis - Spotlight session - Cancer of unknown pri...MCO 2011 - Slide 34 - N. Pavlidis - Spotlight session - Cancer of unknown pri...
MCO 2011 - Slide 34 - N. Pavlidis - Spotlight session - Cancer of unknown pri...European School of Oncology
 
Cytology Paris 2013: presentation selected for a cytopathologist junior prize
Cytology Paris 2013: presentation selected for a cytopathologist junior prizeCytology Paris 2013: presentation selected for a cytopathologist junior prize
Cytology Paris 2013: presentation selected for a cytopathologist junior prizeOKCC/C3O and CREM/université Lorraine
 
Screening for carcinoma prostate
Screening for carcinoma prostateScreening for carcinoma prostate
Screening for carcinoma prostatePrakash Hs
 

Similar to Incidental Adnexal Masses at CT (20)

Screening for ovarian cancer may 15
Screening for ovarian cancer  may 15Screening for ovarian cancer  may 15
Screening for ovarian cancer may 15
 
Screening for ovarian cancer may 15
Screening for ovarian cancer  may 15Screening for ovarian cancer  may 15
Screening for ovarian cancer may 15
 
Jc1
Jc1Jc1
Jc1
 
Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docxOriginal StudyType of Breast Cancer Diagnosis, Screening,a.docx
Original StudyType of Breast Cancer Diagnosis, Screening,a.docx
 
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.comServikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
Servikal Displazi -Pap Smear - Serviks Kanseri - www.jinekolojivegebelik.com
 
Surgical treatment of potentially primary malignant adrenal tumors | Γιώργος...
Surgical treatment of potentially primary malignant adrenal tumors | Γιώργος...Surgical treatment of potentially primary malignant adrenal tumors | Γιώργος...
Surgical treatment of potentially primary malignant adrenal tumors | Γιώργος...
 
Surgical mgmt of axilla in Breast ca patients with negative SLN biopsy.pptx
Surgical mgmt of axilla in Breast ca patients with negative SLN biopsy.pptxSurgical mgmt of axilla in Breast ca patients with negative SLN biopsy.pptx
Surgical mgmt of axilla in Breast ca patients with negative SLN biopsy.pptx
 
TUMOR MARKERS OF COLORECTAL CARCINOMA
TUMOR MARKERS OF  COLORECTAL CARCINOMATUMOR MARKERS OF  COLORECTAL CARCINOMA
TUMOR MARKERS OF COLORECTAL CARCINOMA
 
S E L E C T I V E A X I L L A R Y D I S S E C T I O N I N
S E L E C T I V E  A X I L L A R Y  D I S S E C T I O N  I NS E L E C T I V E  A X I L L A R Y  D I S S E C T I O N  I N
S E L E C T I V E A X I L L A R Y D I S S E C T I O N I N
 
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.comCervical Cancer Screening - HPV - www.jinekolojivegebelik.com
Cervical Cancer Screening - HPV - www.jinekolojivegebelik.com
 
Co-relation of multidetector CT scan based preoperative staging with intra-op...
Co-relation of multidetector CT scan based preoperative staging with intra-op...Co-relation of multidetector CT scan based preoperative staging with intra-op...
Co-relation of multidetector CT scan based preoperative staging with intra-op...
 
Scans and Ovarian Cancer: Everything You Want to Know
Scans and Ovarian Cancer: Everything You Want to KnowScans and Ovarian Cancer: Everything You Want to Know
Scans and Ovarian Cancer: Everything You Want to Know
 
Imaging in breast cancer
Imaging in breast cancerImaging in breast cancer
Imaging in breast cancer
 
Ovarian Tumors, Diagnosis Or Prognosis
Ovarian Tumors, Diagnosis Or PrognosisOvarian Tumors, Diagnosis Or Prognosis
Ovarian Tumors, Diagnosis Or Prognosis
 
Ampullary carcinoma
Ampullary carcinomaAmpullary carcinoma
Ampullary carcinoma
 
MCO 2011 - Slide 34 - N. Pavlidis - Spotlight session - Cancer of unknown pri...
MCO 2011 - Slide 34 - N. Pavlidis - Spotlight session - Cancer of unknown pri...MCO 2011 - Slide 34 - N. Pavlidis - Spotlight session - Cancer of unknown pri...
MCO 2011 - Slide 34 - N. Pavlidis - Spotlight session - Cancer of unknown pri...
 
Cytology Paris 2013: presentation selected for a cytopathologist junior prize
Cytology Paris 2013: presentation selected for a cytopathologist junior prizeCytology Paris 2013: presentation selected for a cytopathologist junior prize
Cytology Paris 2013: presentation selected for a cytopathologist junior prize
 
Barcelona Screening
Barcelona ScreeningBarcelona Screening
Barcelona Screening
 
Seminoma eau
Seminoma eauSeminoma eau
Seminoma eau
 
Screening for carcinoma prostate
Screening for carcinoma prostateScreening for carcinoma prostate
Screening for carcinoma prostate
 

More from Naglaa Mahmoud

Radiology night 10/2015
Radiology night 10/2015Radiology night 10/2015
Radiology night 10/2015Naglaa Mahmoud
 
Gestational trophoblastic disease
Gestational trophoblastic diseaseGestational trophoblastic disease
Gestational trophoblastic diseaseNaglaa Mahmoud
 
Treatment related complications from Chemothearpy
Treatment related complications from ChemothearpyTreatment related complications from Chemothearpy
Treatment related complications from ChemothearpyNaglaa Mahmoud
 
Positive Oral Contrast for Oncology Patients
Positive Oral Contrast for Oncology Patients Positive Oral Contrast for Oncology Patients
Positive Oral Contrast for Oncology Patients Naglaa Mahmoud
 
Secondary Peritoneal Disease
Secondary Peritoneal DiseaseSecondary Peritoneal Disease
Secondary Peritoneal DiseaseNaglaa Mahmoud
 
Digital Breast Tomosynthesis, Microcalcifications
Digital Breast Tomosynthesis, MicrocalcificationsDigital Breast Tomosynthesis, Microcalcifications
Digital Breast Tomosynthesis, MicrocalcificationsNaglaa Mahmoud
 
Breast Cancer not Detected on MRI
Breast Cancer not Detected on MRIBreast Cancer not Detected on MRI
Breast Cancer not Detected on MRINaglaa Mahmoud
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced NephropathyNaglaa Mahmoud
 

More from Naglaa Mahmoud (11)

Breast bpe
Breast bpe Breast bpe
Breast bpe
 
Radiology night 10/2015
Radiology night 10/2015Radiology night 10/2015
Radiology night 10/2015
 
Pulmonary embolism
Pulmonary embolismPulmonary embolism
Pulmonary embolism
 
Gestational trophoblastic disease
Gestational trophoblastic diseaseGestational trophoblastic disease
Gestational trophoblastic disease
 
Treatment related complications from Chemothearpy
Treatment related complications from ChemothearpyTreatment related complications from Chemothearpy
Treatment related complications from Chemothearpy
 
Positive Oral Contrast for Oncology Patients
Positive Oral Contrast for Oncology Patients Positive Oral Contrast for Oncology Patients
Positive Oral Contrast for Oncology Patients
 
Secondary Peritoneal Disease
Secondary Peritoneal DiseaseSecondary Peritoneal Disease
Secondary Peritoneal Disease
 
Digital Breast Tomosynthesis, Microcalcifications
Digital Breast Tomosynthesis, MicrocalcificationsDigital Breast Tomosynthesis, Microcalcifications
Digital Breast Tomosynthesis, Microcalcifications
 
Breast Cancer not Detected on MRI
Breast Cancer not Detected on MRIBreast Cancer not Detected on MRI
Breast Cancer not Detected on MRI
 
H&N post ttt
H&N post tttH&N post ttt
H&N post ttt
 
Contrast Induced Nephropathy
Contrast Induced NephropathyContrast Induced Nephropathy
Contrast Induced Nephropathy
 

Incidental Adnexal Masses at CT

  • 1. Incidental Adnexal Masses Detected at Low- Dose Unenhanced CT in Asymptomatic Women Age 50 and Older: Implications for Clinical Management and Ovarian Cancer Screening ©RSNA, 2010 • radiology.rsna.org By Dr. Naglaa Mahmoud Registrar of Clinical Radiology KCCC
  • 2. Introduction: Ovarian cancer remains the leading cause of gynecologic cancer–related deaths in the United States. Five-year survival for ovarian cancer is greater than 90% for localized disease, but the overall survival is well below 50% because the majority of cases are advanced at diagnosis.
  • 3. Introduction: Unlike transvaginal ultrasonography or MR imaging, CT is not intended for primary pelvic or gynecologic evaluation in women. However, the widespread use of abdominal / pelvic CT for a variety of other indications unavoidably includes adnexal evaluation, often resulting in incidental lesion detection.
  • 4. Introduction: In the case of CT colonography screening in asymptomatic postmenopausal women, the identification of adnexal lesions nearly always represents an unsuspected incidental finding which allows for a unique opportunity to investigate this well-suited cohort.
  • 5. The purpose of this study was: To determine the prevalence, work-up, and outcomes of indeterminate adnexal masses identified at low-dose unenhanced CT scan in asymptomatic women age 50 and older undergoing colonography screening.
  • 6. Materials and Methods: This study was institutional review board approved. Informed consent was waived. The fate of indeterminate adnexal lesions identified at unenhanced CT in 2869 consecutive women (mean age, 57.2 years; age range, 50–97 years) undergoing colonography screening between April 2004 and December 2008 was evaluated.
  • 7. CT Technique CT imaging of the abdomen and pelvis was performed for the purpose of colorectal cancer screening by using a colonographic technique. The preimaging protocol for colonography includes bowel preparation the evening before examination and gaseous distention of the colon during the examination.
  • 8. CT Technique Supine and prone acquisitions were obtained with 8 or 16- detector CT scanners by utilizing 1.25-mm collimation, 120 kVp, static (50–75 mAs) tube current technique, and 1-mm reconstruction interval. For extracolonic evaluation, the supine series was reconstructed with a 5-mm section thickness at 3-mm intervals.
  • 9. CT Technique Extracolonic CT interpretation was performed alongside the prospective colorectal evaluation by one of five board-certified abdominal radiologists, all with at least 10 years of experience in gastrointestinal and genitourinary body CT interpretation. Prospective categorization of extracolonic findings was applied in all cases by utilizing the CT Colonography Reporting and Data System (C-RADS).
  • 10. CT Technique According to C-RADS, E1 (normal finding) and E2 (unimportant finding) categories do not require further work-up, whereas E3 (likely benign but incompletely characterized) and E4 (potentially or definitely important) findings often necessitate further evaluation.
  • 11. Identification of the Study Cohort The positive study cohort was defined by the presence of an adnexal lesion with a C-RADS category of E3 or E4.
  • 12. Results: One hundred eighteen women (mean age, 56.2 years), representing 4.1% of the screening cohort, had an indeterminate adnexal mass (108 unilateral, 10 bilateral; Mean size, 4.1 cm) at prospective CT interpretation. A total of 80 women underwent some combination of further imaging evaluation (n = 76) (transvaginal ultrasonography [ n = 71], pelvic magnetic resonance imaging [ n = 7], contrast material– enhanced CT [ n = 7]) and/or surgery ( n = 26).
  • 13. Results: Mean serum CA-125 level in 33 women was 12.8 U/mL; levels were normal ( < 35 U/mL) in 32 (97%) cases (range, 3–26 U/mL) and mildly elevated (41 U/mL) in 1 case.
  • 14. Results: Final pathologic findings of surgically excised lesions were cystadenoma or cystadenofibroma ( n = 14; 11 serous, three mucinous); non neoplastic cysts ( n = 5; two endometriomas); mature teratoma ( n = 3); hydrosalpinx ( n = 2); fibroma (n = 1); and benign Brenner tumor ( n = 1). Three additional teratomas were diagnosed at index CT only. No ovarian cancers were prospectively identified.
  • 15. Various adnexal pathologic findings identified at routine CT colonography screening and surgically removed after further work-up. CT colonographic images in six women (age range, 51–63 years) show (a)mucinous cystadenoma, (b)bilateral serous cystadenomas,
  • 16. (c) ovarian fibroma, (d) endometrioma,
  • 17. (e) paraovarian inclusion cyst, and (f) hydrosalpinx
  • 18. Results: A systematic search for subsequent diagnosis of ovarian cancer in the larger cohort of 2751 women without an adnexal mass of C-RADS category E3 or E4 at CT colonography revealed 4 cases of ovarian cancer that manifested 15–44 months (mean, 26.8 months) after a negative finding at CT examination.
  • 19. Results: Pathologic diagnoses included 2 cases of mucinous cystadenocarcinoma, 1 case of papillary serous carcinoma, and 1 case of a poorly differentiated adenocarcinoma for which ovarian versus peritoneal origin could not be ascertained.
  • 20. Mucinous cystadenocarcinoma that manifested 3 years after negative findings at CT colonography screening examination in 67-year-old woman. (a) Index CT colonographic image demonstrates symmetric-appearing normal ovaries. (b) Diagnostic contrast-enhanced CT image obtained 3 years later shows a large complex solid and cystic mass, which originated from the left ovary.
  • 21.
  • 22. Discussion: Ovarian cancer has a greater annual mortality than cervical and endometrial cancers combined. Prognosis remains poor in most cases because the disease is usually advanced at diagnosis.
  • 23. Discussion Although effective screening for ovarian cancer is highly desirable, there is currently no convincing evidence that it can reduce mortality among average-risk women. The findings of this study further support this unfortunate situation. Furthermore, a negative finding at CT was not protective against subsequent development of ovarian cancer, with all four cases occurring in this cohort.
  • 24. Discussion: The main factors that diminish the potential utility of screening are that indolent benign adnexal lesions are relatively common in postmenopausal women, but ovarian cancer is relatively rare and tends to grow rapidly. Management algorithms generally recommend further work- up of nearly all discrete adnexal masses detected at CT in postmenopausal women.
  • 25. Discussion: In contrast to ovarian cancer, a number of other extracolonic cancers have been identified at CT colonography screening, generally at an early presymptomatic stage with a favorable outcome. This suggests that ovarian cancer is an aggressive tumor that has a rather narrow window for presymptomatic screening that may preclude effective screening detection in the general population.
  • 26. Discussion: More sophisticated risk factor assessment may be required to effectively identify and manage high-risk cases to improve the overall yield of ovarian cancer screening. Established risk factors include BRCA mutations, Lynch syndrome, family history of ovarian or breast cancer, and a personal history of breast cancer.
  • 27. Limitations of the study All CT examinations were performed by using a colonographic technique with low-dose imaging and without intravenous contrast material. With the exception of ovarian teratomas, the ability to fully characterize adnexal masses at low-dose unenhanced CT is limited.
  • 28. Conclusion: Incidental indeterminate adnexal lesions were relatively common at unenhanced CT scan (4.1%), but subsequent work-up revealed no ovarian cancers. Furthermore, a normal finding at CT was not protective against short-term development of ovarian cancer. More sophisticated risk factor assessment is needed to identify women at higher risk.